ALREADY TAKING STALEVO
STALEVO is indicated for
certain patients with Parkinson's disease experiencing symptom
reemergence due to levodopa "wearing-off."
|
|
|
| |
|
STALEVO contains carbidopa, levodopa and entacapone, and is the most recent advance in levodopa therapy.
If you already take STALEVO, you know that it is clinically proven to provide
more active time during the day—almost an hour and a half each day (1.4 hours).
|
| |
|
Learn more about how STALEVO works.
|
| |
| Look into insurance and assistance with STALEVO.
|
|
|
|
|
 |
 |
| |
|
|
| Learn more about the progression of Parkinson's disease |
| |
 |
|
 |
| |
|
|
If symptoms are reemerging, find out
when to inform your health care professional |
| |
|
|
 |
|
|
|
|
|
Find out about additional support and resources for people with Parkinson's disease
|
|
|
|
| |
| |
|
|
|
|
|
